# Dermorphin

> A potent, highly selective μ-opioid heptapeptide from amphibian skin — a research tool containing a D-amino acid.

- Also known as: [D-Ala2]-dermorphin
- Class: Cognitive
- FDA approved: No
- Canonical page: https://americanpeptide.com/catalog/dermorphin

## Overview

Dermorphin is a naturally occurring heptapeptide first isolated from the skin of South American Phyllomedusa frogs. It is a potent and highly selective agonist at the μ-opioid receptor, several times more potent than morphine by weight in animal assays, and it is notable biochemically for containing a D-amino acid (D-alanine at position 2) — one of the few vertebrate peptides to do so, which is what protects it from rapid enzymatic breakdown. It is used as a pharmacological research tool; it is a controlled-interest opioid compound and is not an approved medicine.

Dermorphin is one of the classic examples of a vertebrate peptide that breaks the all-L rule: its second residue is D-alanine, incorporated post-translationally. That single stereochemical change makes the peptide resistant to the enzymes that would otherwise clear an opioid peptide quickly, and it is a textbook case for why D-amino acids matter in peptide design.

Pharmacologically it is a potent, selective μ-opioid agonist and is studied as a probe of opioid-receptor function and of peptide analgesia. Because it is a strong opioid, it is a research reagent rather than a wellness compound, and it has no approved therapeutic use. This page is a research and educational reference only.

## Mechanism

High-affinity, selective μ-opioid-receptor agonism. The D-Ala2 residue and C-terminal amide confer resistance to peptidases, extending activity relative to all-L opioid peptides.

## Chemistry

| Property | Value |
| --- | --- |
| Molecular formula | C40H50N8O10 |
| Molecular weight | 803.9 Da |

## Research areas

Studied in: Opioid-receptor pharmacology, Analgesia research, Peptide stability (D-amino acids).

## Key research

- Selective μ-opioid agonist — potent and highly μ-selective in receptor and analgesia assays.
- Contains a D-amino acid — D-Ala2 is a rare natural D-residue that confers peptidase resistance.
- Research probe — used to study opioid-receptor pharmacology and peptide stability, not as a therapeutic.
- Not approved — a controlled-interest research opioid with no approved medical use.

## Storage, handling & synthesis

**Storage.** Store lyophilized, frozen, and protected from light; keep reconstituted peptide refrigerated and use within a short window. As a potent opioid research reagent, it also warrants controlled, labeled, restricted-access storage.

**Handling.** Handle as a high-potency compound with appropriate PPE, and verify the D-Ala2 configuration by analysis — an all-L impurity is a different, less stable molecule than dermorphin.

**Synthesis.** A heptapeptide amide whose defining synthetic feature is a D-alanine at position 2 — built by solid-phase synthesis with an Fmoc-D-Ala building block and a C-terminal amide from Rink-amide resin. The D-residue is what resists peptidases; over a seven-residue chain, deletion-sequence removal sets the purity, and identity work must confirm the D-configuration rather than assume the all-L sequence.

## FAQs

### What is dermorphin?

A heptapeptide from amphibian skin that is a potent, selective μ-opioid-receptor agonist, used as a research tool. It contains a rare D-amino acid (D-Ala2).

### Why does the D-amino acid matter?

The D-alanine at position 2 resists enzymatic breakdown, which both extends the peptide’s activity and makes it a classic example of D-amino-acid stabilization in peptide design.

### Is it used clinically?

No — it is a potent opioid studied as a research reagent, with no approved therapeutic use.

### Is it approved?

No. This page is a research and educational reference, not medical advice.

---

Source: AmericanPeptide.com — https://americanpeptide.com/catalog/dermorphin
Data license: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Attribution: AmericanPeptide.com.
Research reference only — computational and educational content, not medical advice.